ABAngela BrancheMDSlidesetRSVCOVID-19International Workshop on COVID-19 Vaccines 2022 - December EditionCOVID-19 Vaccines_Angela BrancheView Slideset
DKDaniel KuritzkesMDVideoRSVMonkeypox Clinical Forum 2022Monkeypox Treatment and Prevention - Daniel KuritzkesView Video
DODimie OgoinaMBBS, FWACP, FMCP-Infectious Diseases, FACP, FIDSAVideoRSVMonkeypox Clinical Forum 2022Comparing the Epidemiology and Clinical Presentation of Monkeypox in Nigeria and the Global North - Dimie OgoinaView Video
COChloe OrkinMBChB, FRCP, MDVideoRSVMonkeypox Clinical Forum 2022Case Recognition and Case Definition in the Multi-Country Outbreak - Chloe OrkinView Video
COChloe OrkinMBChB, FRCP, MDSlidesetRSVMonkeypox Clinical Forum 2022Case Recognition and Case Definition in the Multi-country Outbreak - C. Orkin, MBChB, FRCP, MDView Slideset
DKDaniel KuritzkesMDSlidesetRSVMonkeypox Clinical Forum 2022Monkeypox Treatment and Prevention - D. Kuritzkes, MDView Slideset
DODimie OgoinaMBBS, FWACP, FMCP-Infectious Diseases, FACP, FIDSASlidesetRSVMonkeypox Clinical Forum 2022Comparing the Epidemiology and Clinical Presentation of Monkeypox in Nigeria and the Global North - D. Ogoina, MBBS, FWACP, FMCP-Infectious Diseases, FACP, FIDSAView Slideset
MGMatthew GagnePhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionScientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting Strategy | Matthew GagneView Slideset
PLPaolo LussoMD, PhDVideoHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionPaolo Lusso | mRNA Vaccines for HIVView Video
MGMatthew GagnePhDVideoHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionMatthew Gagne | Scientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting StrategyView Video
TRTracy RuckwardtPhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionVaccines for Respiratory Syncytial Virus | Tracy RuckwardtView Slideset
NPNorbert PardiPhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionDevelopment of Universal Influenza Vaccines Using Nucleoside-Modified mRNA | Norbert PardiView Slideset
